October 11, 2025 - 03:31

The County and its partners convened on Thursday to officially launch the ELEVATE Behavioral Health Workforce Fund, a significant investment of $75 million aimed at enhancing the behavioral health workforce in the region. This initiative is designed to address the growing demand for mental health services and ensure that residents have access to the care they need.
The ELEVATE fund will focus on various strategies, including recruitment, training, and retention of skilled professionals in the behavioral health field. With an increasing number of individuals seeking mental health support, this initiative is timely and crucial. County officials emphasized the importance of building a robust workforce capable of delivering high-quality care to those struggling with mental health challenges.
Community leaders and stakeholders expressed their commitment to collaborating on this initiative, highlighting the potential positive impact on the well-being of residents. The ELEVATE fund represents a proactive step towards creating a healthier community through enhanced mental health services and support.
July 25, 2026 - 03:23
Cyclospora Outbreak Grows, Affecting Nine StatesFederal investigators continue to search for the sources amid the largest number of reported cyclosporiasis cases in US history. Health officials have confirmed that the outbreak has now spread to...
July 24, 2026 - 09:13
The Benefits of Exercise for Mental HealthIt is common knowledge that regular exercise strengthens the heart, builds muscle, and helps manage weight. But according to Dr. John Ratey, a clinical associate professor of psychiatry at Harvard...
July 23, 2026 - 21:07
U.S. health officials investigate new outbreak of parasite cyclosporaFederal health authorities are investigating a new outbreak of the intestinal parasite cyclospora, though they have not yet pinpointed the specific food source responsible for the illnesses. The...
July 23, 2026 - 03:37
US regulators to weigh controversial peptides backed by RFK JrU.S. regulators are preparing to evaluate a class of controversial peptides that have gained a passionate following, partly due to endorsements from Robert F. Kennedy Jr. The compounds, often sold...